| Literature DB >> 33985609 |
George Sie Williams1, Benido Impouma1,2, Franck Mboussou1, Theresa Min-Hyung Lee1, Opeayo Ogundiran1, Charles Okot1, Tatiana Metcalf1, Mary Stephen1, Senait Tekeste Fekadu1, Caitlin M Wolfe1,3, Bridget Farham1, Cristina Hofer4, Bertil Wicht5,6, Claudia Codeço Tores7, Antoine Flahault2, Olivia Keiser2.
Abstract
Epidemic intelligence activities are undertaken by the WHO Regional Office for Africa to support member states in early detection and response to outbreaks to prevent the international spread of diseases. We reviewed epidemic intelligence activities conducted by the organisation from 2017 to 2020, processes used, key results and how lessons learned can be used to strengthen preparedness, early detection and rapid response to outbreaks that may constitute a public health event of international concern. A total of 415 outbreaks were detected and notified to WHO, using both indicator-based and event-based surveillance. Media monitoring contributed to the initial detection of a quarter of all events reported. The most frequent outbreaks detected were vaccine-preventable diseases, followed by food-and-water-borne diseases, vector-borne diseases and viral haemorrhagic fevers. Rapid risk assessments generated evidence and provided the basis for WHO to trigger operational processes to provide rapid support to member states to respond to outbreaks with a potential for international spread. This is crucial in assisting member states in their obligations under the International Health Regulations (IHR) (2005). Member states in the region require scaled-up support, particularly in preventing recurrent outbreaks of infectious diseases and enhancing their event-based surveillance capacities with automated tools and processes.Entities:
Keywords: AFRO; epidemic intelligence; event-based surveillance; indicator-based surveillance; outbreak; rapid risk assessments
Mesh:
Year: 2021 PMID: 33985609 PMCID: PMC8727712 DOI: 10.1017/S095026882100114X
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 2.451
Fig. 1.Steps in the epidemic intelligence process at the WHO Regional Office for Africa adapted from WHO AFRO manual on detection, verification, and risk assessment of acute public health event in the WHO African region.
Infectious disease outbreaks and conditions detected by epidemic intelligence activities (event-based and indicator-based surveillance) and reported to WHO in the African region, 2017–2020
| Year of event/disease category | Year/disease or condition | Event-based surveillance | Indicator-based surveillance | Total |
|---|---|---|---|---|
| Year of event ( | 2017 | 31 (26.1) | 88 (73.9) | 119 (28.7) |
| 2018 | 29 (27.9) | 75 (72.1) | 104 (25.1) | |
| 2019 | 22 (23.2) | 73 (76.8) | 95 (22.9) | |
| 2020 | 22 (22.7) | 75 (77.3) | 97 (23.4) | |
| Events of unknown aetiology ( | Event of unknown aetiology | 2 (66.7) | 1 (33.3) | 3 (75.0) |
| Eruptive fever | 0 (0.0) | 1 (100.0) | 1 (25.0) | |
| Food-and-water-borne diseases ( | Aflatoxicosis | 0 (0.0) | 2 (100.0) | 2 (2.3) |
| Botulism | 0 (0.0) | 1 (100.0) | 1 (1.1) | |
| Cholera | 25 (40.3) | 37 (59.7) | 62 (70.5) | |
| Foodborne disease | 3 (75.0) | 1 (25.0) | 4 (4.5) | |
| Hepatitis A | 0 (0.0) | 1 (100.0) | 1 (1.1) | |
| Hepatitis E | 1 (14.3) | 6 (85.7) | 7 (8.0) | |
| Listeriosis | 0 (0.0) | 2 (100.0) | 2 (2.3) | |
| Shigellosis | 0 (0.0) | 2 (100.0) | 2 (2.3) | |
| Typhoid fever | 1 (20.0) | 4 (80.0) | 5 (5.7) | |
| Undiagnosed diarrhoeal disease | 1 (50.0) | 1 (50.0) | 2 (2.3) | |
| Parasitic diseases ( | Guinea worm disease | 2 (66.7) | 1 (33.3) | 3 (50.0) |
| Scabies | 1 (100.0) | 0 (0.0) | 1 (16.7) | |
| Skin disease | 1 (100.0) | 0 (0.0) | 1 (16.7) | |
| Necrotising cellulitis/fasciitis | 0 (0.0) | 1 (100.0) | 1 (16.7) | |
| Respiratory diseases ( | COVID-19 | 8 (17.0) | 39 (83.0) | 47 (95.9) |
| Influenza A H1N1 | 1 (50.0) | 1 (50.0) | 2 (4.1) | |
| Vaccine-preventable diseases ( | Measles | 10 (27.0) | 27 (73.0) | 37 (34.3) |
| Yellow fever | 1 (4.3) | 22 (95.7) | 23 (21.3) | |
| Poliomyelitis (cVDPV2) | 4 (20.0) | 16 (80.0) | 20 (18.5) | |
| Meningococcal disease | 3 (15.8) | 16 (84.2) | 19 (17.6) | |
| Pertussis | 0 (0.0) | 3 (100.0) | 3 (2.8) | |
| Rubella | 1 (50.0) | 1 (50.0) | 2 (1.9) | |
| Diphtheria | 0 (0.0) | 1 (100.0) | 1 (0.9) | |
| AEFI | 0 (0.0) | 1 (100.0) | 1 (0.9) | |
| Poliomyelitis (pre-iVDPV1) | 1 (100.0) | 0 (0.0) | 1 (0.9) | |
| Rotavirus | 0 (0.0) | 1 (100.0) | 1 (0.9) | |
| Vector-borne diseases ( | Dengue fever | 8 (27.6) | 21 (72.4) | 29 (37.7) |
| Rift Valley fever | 2 (12.5) | 14 (87.5) | 16 (20.8) | |
| Malaria | 7 (53.8) | 6 (46.2) | 13 (16.9) | |
| Chikungunya | 2 (28.6) | 5 (71.4) | 7 (9.1) | |
| Plague | 2 (40.0) | 3 (60.0) | 5 (6.5) | |
| Leishmaniasis | 1 (33.3) | 2 (66.7) | 3 (3.9) | |
| Zika virus disease | 0 (0.0) | 2 (100.0) | 2 (2.6) | |
| Microcephaly | 0 (0.0) | 1 (100.0) | 1 (1.3) | |
| West Nile fever | 0 (0.0) | 1 (100.0) | 1 (1.3) | |
| Viral haemorrhagic fever ( | Crimean-Congo haemorrhagic fever | 5 (19.2) | 21 (80.8) | 26 (48.1) |
| Lassa fever | 1 (5.3) | 18 (94.7) | 19 (35.2) | |
| Ebola virus disease | 1 (16.7) | 5 (83.3) | 6 (11.1) | |
| Marburg | 0 (0.0) | 2 (100.0) | 2 (3.7) | |
| Acute haemorrhagic fever syndrome | 0 (0.0) | 1 (100.0) | 1 (1.9) | |
| Zoonotic diseases ( | Anthrax | 7 (53.8) | 6 (46.2) | 13 (44.8) |
| Monkeypox | 1 (7.1) | 13 (92.9) | 14 (48.3) | |
| Rabies | 1 (50.0) | 1 (50.0) | 2 (6.9) | |
| Grand total | 104 (25.1) | 311 (74.9) | 415 (100.0) |
Fig. 2.A spot map of the geographical distribution of infectious disease outbreaks reported to WHO in the African region, 2017–2020.
Fig. 3.Results of event-based surveillance (media monitoring) undertaken at WHO Regional Office for Africa leading to detection of new infectious disease public health events in the African region, 2017–2020.
Percent of events detected and positive predictive values of the most frequent events identified through epidemic intelligence in the WHO African region, 2017–2020
| Event | Frequency of event | Detected events | Per cent detected2 (%) | Media articles | Media signals selected | Signals confirmed/monitored | PPV (%) |
|---|---|---|---|---|---|---|---|
| Cholera | 62 | 25 | 40.3 | 25 059 | 153 | 64 | 41.8 |
| COVID-19 | 47 | 8 | 17.0 | 1 256 060 | 164 | 14 | 8.5 |
| Measles | 37 | 10 | 27.0 | 27 012 | 59 | 34 | 57.6 |
| Dengue fever | 29 | 8 | 27.6 | 5525 | 20 | 10 | 50.0 |
| CCHF | 26 | 5 | 19.2 | 1932 | 22 | 9 | 40.9 |
| Yellow fever | 23 | 1 | 4.3 | 6136 | 21 | 13 | 61.9 |
| Poliomyelitis | 20 | 4 | 20.0 | 15 161 | 11 | 1 | 9.1 |
| Meningococcal disease | 19 | 3 | 15.8 | 12 505 | 13 | 6 | 46.2 |
| Lassa fever | 19 | 1 | 5.3 | 6418 | 36 | 7 | 19.4 |
| Rift Valley fever | 16 | 2 | 12.5 | 1186 | 9 | 2 | 22.2 |
| Monkeypox | 14 | 1 | 7.1 | 1239 | 16 | 6 | 37.5 |
| Anthrax | 13 | 7 | 53.8 | 1563 | 46 | 23 | 50.0 |
| Malaria | 13 | 7 | 53.8 | 36 150 | 82 | 40 | 48.8 |
| Hepatitis E | 7 | 1 | 14.3 | 871 | 25 | 5 | 20.0 |
| Chikungunya | 7 | 2 | 28.6 | 2413 | 4 | 2 | 50.0 |
| Ebola virus disease | 6 | 1 | 16.7 | 92 677 | 337 | 100 | 29.7 |
| Total | 358 | 86 | 24.0 | 1 491 907 | 1018 | 336 | 33.0 |
Detected events are events detected via epidemic intelligence platforms before they were officially reported to WHO.
Per cent of events detected via the epidemic intelligence platforms before being officially reported to WHO.
PPV, positive predictive value, is defined as the proportion of selected media signals that were confirmed or monitored after verification.
Fig. 4.National, regional, and global levels risk characterization for the top eleven infectious disease outbreaks with frequent rapid risk assessments, WHO African region, 2017–2020 (N = 178).